| Prevalence of psychoactive substance use Prevalence of medication use Prevalence of drug use Drug prevention Treatment supply Treatment demand Health consequences Harm reduction Drug-related crimes Drug market Drug use and prison Monitoring of publications Attitudes to legal framework changes |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2022
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| Total number of PWID who were tested | 262 | 118 | 262 |
| Males | 192 | 94 | 192 |
| Females | 70 | 24 | 70 |
| Number of PWID with a positive test result | 38 | 21 | 197 |
| Males | 30 | 17 | 150 |
| Females | 8 | 4 | 47 |
| Proportion positive (%) | 14.5% | 17.8% | 75.2% |
| Males | 15.6% | 18.1% | 78.1% |
| Females | 11.4% | 16.7% | 67.1% |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2022 (by age groups)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| Age <25 | |||
| Number of PWID who were tested | 16 | 8 | 16 |
| Number of PWID with a positive test result | 0 | 1 | 4 |
| Proportion positive (%) | 0.0% | 12.5% | 25.0% |
| Age 25-34 | |||
| Number of PWID who were tested | 22 | 15 | 22 |
| Number of PWID with a positive test result | 3 | 2 | 11 |
| Proportion positive (%) | 13.6% | 13.3% | 50.0% |
| Age > 34 | |||
| Number of PWID who were tested | 224 | 95 | 224 |
| Number of PWID with a positive test result | 35 | 18 | 182 |
| Proportion positive (%) | 15.6% | 18.9% | 81.25% |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2022 (by years since first injection)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| 2 to <5 years since first injection | |||
| Number of PWID who were tested | 5 | 2 | 5 |
| Number of PWID with a positive test result | 0 | 1 | 2 |
| Proportion positive (%) | 0.0% | 50.0% | 40.0% |
| 5 to <10 years since first injection | |||
| Number of PWID who were tested | 18 | 9 | 18 |
| Number of PWID with a positive test result | 2 | 0 | 6 |
| Proportion positive (%) | 11.1% | 0.0% | 33.3% |
| 10 or more years since first injection | |||
| Number of PWID who were tested | 237 | 106 | 237 |
| Number of PWID with a positive test result | 36 | 20 | 189 |
| Proportion positive (%) | 15.2% | 18.9% | 79.7% |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2022 (by primary drug)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| PWID with primary drug opioids | |||
| Number of PWID who were tested | 226 | 96 | 226 |
| Number of PWID with a positive test result | 36 | 18 | 195 |
| Proportion positive (%) | 15.9% | 18.75% | 86.3% |
| PWID with primary drug cocaine | |||
| Number of PWID who were tested | 5 | 5 | 5 |
| Number of PWID with a positive test result | 1 | 2 | 1 |
| Proportion positive (%) | 20.0% | 40.0% | 20.0% |
| PWID with primary drug stimulants other than cocaine | |||
| Number of PWID who were tested | 22 | 10 | 22 |
| Number of PWID with a positive test result | 0 | 1 | 0 |
| Proportion positive (%) | 0.0% | 10.0% | 0.0% |
| PWID with primary drug other | |||
| Number of PWID who were tested | 7 | 6 | 7 |
| Number of PWID with a positive test result | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2022 (by contact with drug treatment in the last 12 months)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| PWID who have been in contact with drug treatment services in the last 12 months | |||
| Number of PWID who were tested | 207 | 78 | 207 |
| Number of PWID with a positive test result | 35 | 18 | 182 |
| Proportion positive (%) | 16.9% | 23.1% | 87.9% |
| PWID who have not been in contact with drug treatment services in the last 12 months | |||
| Number of PWID who were tested | 46 | 33 | 46 |
| Number of PWID with a positive test result | 3 | 3 | 12 |
| Proportion positive (%) | 6.5% | 9.1% | 26.1% |
| PWID with missing information on drug treatment contact | |||
| Number of PWID who were tested | 9 | 7 | 9 |
| Number of PWID with a positive test result | 0 | 0 | 3 |
Prevalence of HIV and hepatitis B/C infection among people who inject drugs (PWID) in 2022 (by imprisonment)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | |
| PWID ever in prison | |||
| Number of PWID who were tested | 4 | 2 | 4 |
| Number of PWID with a positive test result | 2 | 1 | 4 |
| Proportion positive (%) | 50.0% | 50.0% | 100.0% |
| PWID never in prison | |||
| Number of PWID who were tested | 215 | 93 | 215 |
| Number of PWID with a positive test result | 25 | 17 | 160 |
| Proportion positive (%) | 11.6% | 18.3% | 74.4% |
| PWID with missing information on prison history | |||
| Number of PWID who were tested | 43 | 23 | 43 |
| Number of PWID with a positive test result | 11 | 3 | 33 |
Source: State Psychiatric Hospital for Treatment of Drug Addiction and Alcoholism (SPHTDAA), Sofia, NFP, NCPHA.